American National Group Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
ANG-PD$22.59+3.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Index to Consolidated Financial Statements and Schedules
| Reports of Independent Registered Public Accounting Firm (Deloitte & Touche LLP, Houston, Texas, Auditor Firm ID: 34) | F-2 |
|---|---|
| Consolidated Financial Statements: | |
| Consolidated Statements of Financial Position as of December 31, 2025 and 2024 | F-4 |
| Consolidated Statements of Operations for the years ended December 31, 2025, 2024 and 2023 | F-6 |
| Consolidated Statements of Comprehensive Income for the years ended December 31, 2025, 2024 and 2023 | F-7 |
| Consolidated Statements of Changes in Stockholders’ Equity for the years ended December 31, 2025, 2024 and 2023 | F-8 |
| Consolidated Statements of Cash Flows for the years ended December 31, 2025, 2024 and 2023 | F-9 |
| Notes to Consolidated Financial Statements: | |
| Note 1. Organization and Description of the Company | F-11 |
| Note 2. Summary of Significant Accounting Policies | F-11 |
| Note 3. Available for Sale Fixed Maturity Securities | F-21 |
| Note 4. Equity Securities | F-23 |
| Note 5. Mortgage Loans on Real Estate | F-24 |
| Note 6. Private Loans | F-27 |
| Note 7. Real Estate and Real Estate Partnerships | F-27 |
| Note 8. Variable Interest Entities and Equity Method Investments | F-28 |
| Note 9. Derivative Instruments | F-29 |
| Note 10. Net Investment Income and Investment Related Gains (Losses) | F-33 |
| Note 11. Fair Value of Financial Instruments | F-34 |
| Note 12. Reinsurance | F-43 |
| Note 13. Separate Account Assets and Liabilities | F-45 |
| Note 14. Deferred Policy Acquisitions Costs, Deferred Sales Inducements and Value of Business Acquired | F-46 |
| Note 15. Intangible Assets | F-48 |
| Note 16. Acquisitions | F-49 |
| Note 17. Future Policy Benefits | F-50 |
| Note 18. Policyholders’ Account Balances | F-55 |
| Note 19. Market Risk Benefits | F-58 |
| Note 20. Long Term Borrowings | F-59 |
| Note 21. Income Taxes | F-61 |
| Note 22. Stockholders’ Equity | F-64 |
| Note 23. Accumulated Other Comprehensive Income | F-65 |
| Note 24. Statutory Financial Information and Dividend Restrictions | F-65 |
| Note 25. Related Party Transactions | F-67 |
| Note 26. Segment Reporting | F-68 |
| Note 27. Financial Commitments and Contingencies | F-71 |
| Note 28. Discontinued Operations | F-72 |
| Note 29. Subsequent Events | F-73 |
| Schedules: | |
| Schedule I. Summary of Investments, Other Than Investments in Related Parties | F-74 |
| Schedule II. Condensed Financial Information of Registrant | F-75 |
| Schedule III. Supplementary Insurance Information | F-78 |
| Schedule IV. Reinsurance | F-79 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.